MLAB · Mesa Laboratories Inc /Co/
$130.66
+5.19 (+4.14%)
At close · Sep 2
View the 10-K filed Jun 3, 2026
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$702.11M
Shares
5.60M
MLAB metrics
88 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$125.47
Market cap
$702.11M
Price action
19 metricsPrice change (1W)
-1.5%
Price change (30D)
+20.1%
Price change (3M)
+17.6%
Price change (6M)
+37.3%
Price change (YTD)
+59.8%
Price change (1Y)
+85.2%
Trailing year
Price change (5Y)
-53.3%
52-week high
$129.09
52-week low
$59.53
Change from 52-week high
-2.8%
Change from 52-week low
+110.8%
Annualized volatility
55.7%
Beta
1.4
RSI (14D)
66.4
Price vs SMA 50
+18.9%
Price vs SMA 200
+33.9%
Avg volume (3M)
192,150
Relative volume
0.6
Average dollar volume
$20.06M
Company
3 metricsSector
Technology
Industry
Scientific & Technical Instruments
Shares outstanding
5.60M
Valuation
12 metricsP / E (TTM)
147.6
Trailing earnings · reciprocal yield 0.7%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.8×
reciprocal yield 35.6%
P / book
3.7
reciprocal yield 26.9%
FCF yield
7.5%
TTM · current market cap
Buyback yield
0.0%
P / FCF
13.3
reciprocal yield 7.5%
P / operating cash flow
12.6
reciprocal yield 7.9%
Earnings yield
0.7%
Historical valuation
8 metricsP / E historical average (3Y)
223.0×
reciprocal yield 0.4%
P / E historical average (5Y)
323.6×
reciprocal yield 0.3%
EV / revenue historical average (3Y)
2.4×
reciprocal yield 40.9%
EV / revenue historical average (5Y)
2.4×
reciprocal yield 40.9%
EV / EBIT historical average (3Y)
30.8×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
30.8×
reciprocal yield 3.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
0.5%
Trailing 12 months
Payout ratio
73.6%
Shareholder yield
—
Dividend / share (TTM)
$0.64
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-31
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-10
Profitability
9 metricsGross margin
64.2%
Operating margin
9.0%
Trailing 12 months
Net margin
1.9%
Gross profit (TTM)
$160.34M
Operating profit (TTM)
$22.48M
Net income (TTM)
$4.80M
Trailing 12 months
Diluted EPS (TTM)
$0.85
FCF margin
21.2%
Effective tax rate
48.7%
Growth
11 metricsRevenue growth YoY
+1.0%
Year over year
Net income growth YoY
-40.3%
Revenue (TTM)
$249.72M
Trailing 12 months
EPS growth YoY
-42.4%
Shares change YoY
+3.7%
Year over year · more shares
Revenue CAGR (3Y)
+4.4%
Revenue CAGR (5Y)
+13.2%
EPS CAGR (3Y)
+92.4%
EPS CAGR (5Y)
+13.6%
FCF CAGR (3Y)
+19.1%
FCF CAGR (5Y)
+2.4%
Quality
14 metricsReturn on equity
2.5%
Return on assets
1.1%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
$37.06M
Free cash flow (TTM)
$52.87M
Quick ratio
1.3
Interest coverage
2.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$30.70M
Total assets
$419.22M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
$55.67M
Capital expenditures (TTM)
$2.80M
R&D (TTM)
$20.05M
SG&A (TTM)
—
Stock compensation (TTM)
$16.35M
R&D / revenue
8.0%
Stock compensation / revenue
6.5%
Ownership (13F)
3 metrics13F filers
158
13F filer change QoQ
-3
Institutional ownership
89.5%
Short interest
3 metricsShort interest
6.0%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
68 / 100
Insider activity
2 metricsNet insider buying (90D)
−$667,805
Insider-sentiment score
30 / 100
Risk flags
1 metricsGoing concern
—